✦ LIBER ✦

Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to III

✍ Scribed by Lotterer, E.; Stiehl, A.; Raedsch, R.; Foelsch, U.R.; Bircher, J.

Book ID: 122502357
Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 396 KB
Volume: 10
Category: Article
ISSN: 0168-8278
DOI: 10.1016/0168-8278(90)90134-D

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ursodeoxycholic acid and prednisolone ve

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis

✍ Maria Leuschner; Sükrettin Güldütuna; Tiangeng You; Klaus Hübner; Susan Bhatti; 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 674 KB

Effects of ursodeoxycholic acid after 4

Effects of ursodeoxycholic acid after 4 to 12 years of therapy in early and late stages of primary biliary cirrhosis

✍ Ulrich Leuschner; Sükrettin Güldütuna; Matthias Imhof; Klaus Hübner; Ala Benjami 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 715 KB

Silymarin in the Treatment of Patients W

Silymarin in the Treatment of Patients With Primary Biliary Cirrhosis With a Suboptimal Response to Ursodeoxycholic Acid

✍ Paul Angulo; Tushar Patel; Roberta A. Jorgensen; Terry M. Therneau; Keith D. Lin 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Oral budesonide in the treatment of pati

Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid

✍ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 236 KB 👁 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid

No evidence for involvement of the inter

No evidence for involvement of the interleukin-10 −592 promoter polymorphism in genetic susceptibility to primary biliary cirrhosis

✍ Francesco Zappala; Jane Grove; Fiona E. Watt; Ann K. Daly; Christopher P. Day; M 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 95 KB

1307 VALIDATION OF THE BARCELONA CRITERI

1307 VALIDATION OF THE BARCELONA CRITERIA OF BIOCHEMICAL RESPONSE TO URSODEOXYCHOLIC ACID IN PRIMARY BILIARY CIRRHOSIS: ALREADY APPLICABLE IN THE SUBSEQUENT FIVE YEARS

✍ Pares, A.; Caballería, L.; Mas, A. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 41 KB